Novel mutations within the RFX-B gene and partial rescue of MHC and related genes through exogenous class II transactivator in RFX-B-deficient cells

Journal of Immunology

Volumn 164, Issue 7, 2000, Pages 3666-3674

  Nagarajan, Uma M ^a   Peijnenburg, Ad ^b   Gobin, Sam J P ^b   Boss, Jeremy M ^a   Van Den Elsen, Peter J ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ARTICLE; COMBINED IMMUNODEFICIENCY; GENE MUTATION; HUMAN; HUMAN CELL; LYMPHOCYTE COUNT; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; PROMOTER REGION;

EID: 0034176748     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.7.3666     Document Type: Article

References (60)

1. Germain, R. N. 1994. MHC-dependent antigen processing and peptide presentation providing ligands for T lymphocyte activation. Cell 76:287.
2. Jameson, S. C., and M. J. Bevan. 1998. T cell selection. Curr. Opin. Immunol. 10:214.
3. van den Elsen, P. J., M. C. Peijnenburg, J. A. Van Eggermond, and S. J. P. Gobin. 1998. Shared regulatory elements in the promoters of MHC class I and class II genes. Immunol. Today 19:308.
4. Klein, C., B. Lisowska-Grospierre, F. LeDeist, A. Fischer, and C. Griscelli. 1993. Major histocompatibility complex class II deficiency: clinical manifestations, immunologic features and outcome. J. Pediatr. 123:921.
5. Lambert, M., M. C Van Eggermond, M. Andrien, F. Mascart, E. Vamos, E. Dupont, and P. van den Elsen. 1991. Analysis of the peripheral T-cell compartment in the MHC class li deficiency syndrome. Res. Immunol. 142:789.
6. Mach, B., V. Steimle, E. Martinez-Soria, and W. Reith. 1996. Regulation of MHC class II genes: lessons from a disease. Annu. Rev. Immunol. 14:301.
7. Boss, J. M. 1997. Regulation of transcription of MHC class II genes. Curr. Opin. Immunol. 9:107.
8. 2-microglobulin genes. Immunity 9:531.
9. Gobin, S. J. P., A. Peijnenburg, V. Keijsers, and P. J. van den Elsen. 1997. Site α is crucial for two routes of IFN-γ-induced MHC class I transactivation: the ISRE-mediate route and a novel pathway involving CIITA. Immunity 6:601.
10. Martin, B. K., K.-C. Chin, J. C. Olsen, C. A. Skinner, A. Dey, K. Ozato, and J. P.-Y. Ting. 1997. Induction of MHC class I expression by the MHC class II transactivator CIITA. Immunity 6:581.
11. Glimcher, L. H., and C. J. Kara. 1992. Sequences and factors: a guide to MHC class II transcription. In Annual Reviews of Immunology, 10th ed. W. E. Paul, C. Garrison Fathman, and H. Metzger, eds. Annual Reviews Inc., Palo Alto, CA, p. 13.
12. Ting, J. P.-Y., and A. S. Baldwin. 1993. Regulation of MHC gene expression. Curr. Opin. Immunol. 5:8.
13. van den Elsen, P. J., S. J. P. Gobin, M. C. J. A. van Eggermond, and A. Peijnenburg. 1998. Regulation of MHC class I and II gene transcription: differences and similarities. Immunogenetics 48:208.
14. Rohn, W. M., J. Lee, and E. N. Benveniste. 1996. Regulation of MHC class II expression. CRC Crit. Rev. Immunol. 16:311.
15. Reith, W., S. Satola, C. H. Sanchez, I. Amaldi, B. Lisowska-Grospierre, C. Griscelli, M. R. Hadam, and B. Mach. 1988. Congenital immunodeficency with a regulatory defect in MHC class II gene expression lacks a specific HLA-DR promoter binding protein, RF-X. Cell 53:897.
16. Moreno, C. S., P. Emery, J. E. West, B. Durand, W. Reith, B. Mach, and J. M. Boss. 1995. Purified X2BP cooperatively binds the class II MHC X box region in the presence of purified RFX, the X box factor deficient in the bare lymphocyte syndrome. J. Immunol. 155:4313.
17. Moreno, C. S., G. Beresford, P. Louis-Plence, A. C. Morris, and J. M. Boss. 1999. CREB regulates MHC class II expression in a CIITA-dependent manner. Immunity 10:143.
18. Zeleznik-Le, N. J., J. C. Azizkhan, and J. P.-Y Ting. 1991. Affinity-purified CCAAT-box-bmding protein (YEBP) functionally regulates expression of a human class II major histocompatibility complex gene and the herpes simplex virus thymidine kinase gene. Proc. Natl. Acad. Sci. USA 88:1873.
19. Schoneich, J., J. L. Lee, P. Mansky, M. Sheffery, and S. Y Yang. 1997. The pentanucleotide ATTGG, the "inverted CCAAT", is an essential element for HLA class I gene transcription. J. Immunol. 158:4788.
20. Wright, K. L., B. J. Vilen, Y. Itoh-Lindstrom, T. L. Moore, G. Li, M. Criscitello, P. Cogswell, J. B. Clarke, and J. P.-Y. Ting. 1994. CCAAT box-binding protein, NF-Y, facilitates in vivo recruitment of upstream DNA-binding transcription factors. EMBO J. 13:4042.
21. Reith, W., C. A. Siegrist, B. Durand, E. Barras, and B. Mach. 1994. Function of major histocompatibility complex class II promoters requires cooperative binding between factors RFX and NF-Y. Proc. Natl. Acad. Sci. USA 91:554.
22. Louis-Plence, P., C. S. Moreno, and J. M. Boss. 1997. Formation of a regulatory factor X/X2 box-binding protein/nuclear factor-Y multiprotein complex on the conserved regulatory regions of HLA class II genes. J. Immunol. 159:3899.
23. Fontes, J. D., N. Jabrane-Ferrat, and B. M. Peterlin. 1997. Assembly of functional regulatory complexes on MHC class II promoters in vivo. J. Mol. Biol. 270:336.
24. Linhoff, M. W., K. L. Wright, and J. P. Y. Ting. 1997. CCAAT-binding factor NF-Y and RFX are required for in vivo assembly of a nucleoprotein complex that spans 250 base pairs: the invariant chain promoter as a model. Mol. Cell. Biol. 17:4589.
25. Kara, C. J., and L. H. Glimcher. 1991. In vivo footprinting of MHC class II genes: bare promoters in the bare lymphocyte syndrome. Science 252:709.
26. Kara, C. J., and L. H. Glimcher. 1993. Three in vivo promoter phenotypes in MHC class II deficient combined immunodeficiency. Immunogenetics 37:227.
27. Steimle, V., L. A. Otten, M. Zufferey, and B. Mach. 1993. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell 75:135.
28. Scholl, T., S. K. Mahanta, and J. L. Strominger. 1997. Specific complex formation between the type II bare lymphocyte syndrome-associated transactivators CIITA and RFX5. Proc. Natl. Acad. Sci. USA 94:6330.
29. Fontes, J. D., S. Kanazawa, D. Jean, and B. M. Peterlin. 1999. Interactions between the class II transactivator and CREB binding protein increase transcription of major histocompatibility complex class II genes. Mol. Cell. Biol. 19:941.
30. Mahanta, S. K., T. Scholl, F.-C. Yang, and J. L. Strominger. 1997. Transactivation by CIITA, the type II bare lymphocyte syndrome-associated factor, requires participation of multiple regions of the TATA box binding protein. Proc. Natl. Acad. Sci. USA 94:6324.
31. Riley, J. L., S. D. Westerheide, J. A. Price, J. A. Brown, and J. M. Boss. 1995. Activation of class II MHC genes requires both the X box region and the class II transactivator (CIITA). Immunity 2:533.
32. Zhou, H., and L. H. Glimcher. 1995. Human MHC class II gene transcription directed by the carboxyl terminus of CIITA, one of the defective genes in type II MHC combined immune deficiency. Immunity 2:545.
33. Kohonen-Corish, M. R. J., R. V. Blanden, and N. J. C. King. 1989. Induction of cell surface expression of HLA antigens by human IFN-γ encoded by recombinant vaccinia virus. J. Immunol. 143:623.
34. Bontron, S., V. Steimle, C. Ucla, and B. Mach. 1997. Two novel mutations in the MHC class II transactivator CIITA in a second patient from MHC class II deficiency complementation group A. Hum. Genet. 99:541.
35. Moreno, C. S., E. M. Rogers, J. A. Brown, and J. M. Boss. 1997. Regulatory factor X, a bare lymphocyte syndrome transcription factor, is a multimeric phosphoproteinn complex. J. Immunol. 158:5841.
36. Masternak, K., E. Barras, M. Zufferey, B. Conrad, G. Corthals, R. Aebersold, J.-C. Sanchez, D. F. Hochstrasser, B. Mach, and W. Reith. 1998. A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients. Nat. Gen. 20:273.
37. Nagarajan, U. M., P. Louis-Plence, A. DeSandro, R. Nilsen, A. Bushey, and J. M. Boss. 1999. RFX-B is the gene responsible for the most common cause of the bare lymphocyte syndrome, a MHC class II immunodeficiency. Immunity 10:153.
38. Steimle, V., B. Durand, B. Emmanuele, M. Zufferey, M. R. Hadam, B. Mach, and W. Reith. 1995. A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome). Genes Dev. 9:1021.
39. Villard, J., W. Reith, E. Barras, A. Gos, M. A. Morris, S. E. Antonarakis, P. J. van den Elsen, and B. Mach. 1997. Analysis of mutations and chromosomal localisation of the gene encoding RFX5, a novel transcription factor affected in major histocompatibility complex class II deficiency. Hum. Mutat. 10:430.
40. Durand, B., P. Sperisen, P. Emery, E. Barras, M. Zufferey, B. Mach, and W. Reith. 1997. RFXAP, a novel subunit of the RFX DNA binding complex, is mutated in MHC class II deficiency. EMBO J. 16:1045.
41. Villard, J., B. Lisowska-Grospierre, P. van den Elsen, A. Fischer, W. Reith, and B. Mach. 1997. Mutation of RFXAP, a regulator of MHC class II genes, in primary MHC class II deficiency. N. Engl. J. Med. 337:748.
42. Westerheide, S. D., and J. M. Boss. 1999. Orientation and positional mapping of the subunits of the multicomponent transcription factors RFX and X2BP to the major histocompatibility complex class II transcriptional enhancer. Nucleic Acids Res. 27:1635.
43. Godthelp, B. C., M. C. J. A. Eggermond, A. Peijnenburg, I. Tezcan, S. van Lierde, M. J. van Tol, J. M. Vossen, and P. J. van den Elsen. 1999. Incomplete T-cell immune reconstitution in two major histocompatibility complex class II-deficiency/bare lymphocyte syndrome patients after HLA-identical sibling bone marrow transplantation. Blood 94:348.
44. Peijneburg, A., B. Godthelp, A. van Boxel-Dezaire, and P. J. van den Elsen. 1995. Definition of a novel complementation group in MHC class II deficiency. Immunogenetics 41:287.
45. Peijnenburg, A., M. C. J. A. van Eggermond, R. van den Berg, O. Sanal, J. M. J. J. Vossen, and P. J. van den Elsen. 1999. Molecular analysis of an MHC class II deficiency patient reveals a novel mutation in the RFX5 gene. Immunogenetics 49:338.
46. Peijnenburg, A., M. C. J. A. van Eggermond, S. J. P. Gobin, R. van den Berg, B. C. Godthelp, J. M. J. J. Vossen, and P. J. van den Elsen. 1999. Discoordinate expression of invariant chain and MHC class II genes in class II tranactivator-transfected fibroblasts defective for RFX5. J. Immunol. 163:794.
47. Peijnenburg, A., S. J. P. Gobin, M. C. J. A. van Eggermond, B. C. Bodthelp, N. van Graafeiland, and P. J. van den Elsen. 1997. Introduction of exogenous class II trans-activator in MHC class II-deficient AB1 fibroblasts results in incomplete rescue of MHC class II antigen expression. J. Immunol. 159:2720.
48. Lisowska-Grospierre, B., M.-C. Fondaneche, M.-P. Rols, C. Griscelli, and A. Fischer. 1994. Two complementation groups account for most cases of inherited MHC class II deficiency. Hum. Mol. Gen. 3:953.
49. Ausubel, K., and B. Gitler. 1987. Swallow syncope in an otherwise healthy young man. Am. Heart J. 113:831.
50. Brown, J. A., E. M. Rogers, and J. M. Boss. 1988. The MHC class II transactivator (CIITA) requires conserved leucine charged domains for interactions with the conserved W box promoter element. Nucleic Acids Res. 26:4128.
51. Chen, C., and H. Okayama. 1987. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell Biol. 7:2745.
52. Riley, J. L., and J. M. Boss. 1993. Class II MHC transcriptional mutants are defective in higher order complex formation. J. Immunol. 151:6942.
53. Rebai, N., B. Malissen, M. Pierres, R. S. Accolla, G. Corte, and C. Mawas. 1983. Distinct HLA-DR epitopes and distinct families of HLA-DR molecules defined by 15 monoclonal antibodies either DR or allo-anti-Ia crossreacting with human DR. Eur. J. Immunol. 13:106.
54. Spits, H., J. Borst, M. Giphart, J. Coligan, C. Terhorst, and J. E. de Vries. 1984. HLA-DC antigens can serve as recognition elements of human cytotoxic T lymphocytes. Eur. J. Immunol. 14:299.
55. Vandekerckhove, B. A. E., G. Datema, F. Koning, E. Goulmy, G. G. Persijn, J. J. van Rood, F. H. J. Claas, and J. E. de Vries. 1990. Analysis of the donor-specific cytotoxic T lymphocyte repertoire in a patient with a long term surviving allograft. J. Immunol. 144:1288.
56. Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl. 1987. Current Protocols in Molecular Biology. Wiley, Boston.
57. Steimle, V., C.-A. Siegrist, A. Mottet, B. Lisowska-Grospierre, and B. Mach. 1994. Regulation of MHC class II expression by interferon-γ mediated by the transactivator gene CIITA. Science 265:106.
58. Rigaud, G., F. Paiola, and R. S. Accolla. 1994. In vivo modification of major histocompatibility complex class II DRA promoter occupancy mediated by the AIR-1 trans-activator. Eur. J. Biochem. 24:2415.
59. Rigaud, G., A. De Lerma Barbaro, M. Nicolis, T. Cestari, D. Ramarli, A. P. Riviera, and R. S. Accolla. 1996. Induction of CIITA and modification of in vivo HLA-DR promoter occupancy in normal thymic epithelial cells treated with IFN-γ: similarities and distinctions with respect to HLA-DR constitutive B cells. J. Immunol. 156:4254.
60. Wright, K. L., K.-C. Chin, M. Linhoff, C. Skinner, G. Li, J. M. Boss. G. R. Stark, and J. P.-Y. Ting. 1998. CIITA stimulation of transcription factor binding to major histocompatibility complex class II and associated promoters in vivo. Proc. Natl. Acad. Sci. USA 95:6267.